This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma Deutschland, Gmbh. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Klaus Steinmeyer: Innovator in Potassium Channel Research
Introduction
Klaus Steinmeyer is a notable inventor based in Frankfurt, Germany. He has made significant contributions to the field of molecular biology, particularly in the study of potassium channels. His work has implications for understanding various physiological processes and potential therapeutic applications.
Latest Patents
Klaus Steinmeyer holds 1 patent related to a nucleic acid molecule encoding the potassium channel protein, KCNQ5. This patent describes the DNA encoding KCNQ5 or a polypeptide having KCNQ5 activity, along with related vectors, host cells, and methods. Additionally, it includes a screening assay for the identification of compounds that modify the activity of the potassium channel KCNQ5.
Career Highlights
Steinmeyer is currently employed at Aventis Pharma Deutschland GmbH, where he continues to advance research in pharmacology and molecular biology. His work at the company has allowed him to collaborate with leading scientists in the field.
Collaborations
Some of his notable coworkers include Christian Lerche and Guiscard Seebohm, who have also contributed to advancements in potassium channel research.
Conclusion
Klaus Steinmeyer's innovative work in the field of potassium channels exemplifies the importance of research in molecular biology. His contributions continue to influence the scientific community and pave the way for future discoveries.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile